Sigaroudi, Ali <br/><br/>
Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.  [electronic resource] 

 -  European journal of clinical pharmacology  Mar 2016 
 - 377-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-015-1991-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acne Vulgaris--drug therapy<br/>Adult<br/>Anti-Bacterial Agents--pharmacology<br/>Anticonvulsants--blood<br/>Carbamazepine--analogs & derivatives<br/>Drug Interactions<br/>Epilepsy--drug therapy<br/>Female<br/>Humans<br/>Oxcarbazepine<br/>Rifampin--pharmacology